LN-145-S1

Drug identity checked against registry records

Also recorded as TIL, autologous tumor infiltrating lymphocytes; TIL, autologous tumor-infiltrating lymphocytes, PD-1-selected TIL

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.